MI Bioresearch (MI), the preclinical oncology solutions business of Covance, offers in vitro and in vivo pharmacology services, in vivo imaging technologies, and focal radiation capabilities to support your research programs. Our team helps you explore the effects of drugs and biologics using both human and syngeneic tumor models. MI provides you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough